Cart
sales@molnova.com
Epaminurad HCl
CAS No. 1198153-46-6
Epaminurad HCl( —— )
Catalog No. M34243 CAS No. 1198153-46-6
Epaminurad HCl is a URAT1 inhibitor with partial inhibition of OAT1 and OAT3 (organic anion transporters).Epaminurad HCl is a pro-uric acid excretory agent used for the prevention and treatment of gout and hyperuricemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 197 | In Stock |
|
| 5MG | 179 | In Stock |
|
| 10MG | 293 | In Stock |
|
| 25MG | 466 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEpaminurad HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpaminurad HCl is a URAT1 inhibitor with partial inhibition of OAT1 and OAT3 (organic anion transporters).Epaminurad HCl is a pro-uric acid excretory agent used for the prevention and treatment of gout and hyperuricemia.
-
DescriptionEpaminurad HCl is a URAT1 inhibitor with partial inhibition of OAT1 and OAT3 (organic anion transporters).Epaminurad HCl is a pro-uric acid excretory agent used for the prevention and treatment of gout and hyperuricemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1198153-46-6
-
Formula Weight450.51
-
Molecular FormulaC14H11Br2ClN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=C(C1=CC(Br)=C(O)C(Br)=C1)N2C=3C=NC=CC3OCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Isocucurbitacin D
Isocucurbitacin D showed a cytotoxic effect with disruption of target protein cofilin.
-
OXYPEUCEDANIN HYDRAT...
Oxypeucedanin hydrate is a furanocoumarin. It has a role as a metabolite.
-
Didymin
Didymin has antioxidant property. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma, may used for neuroblastoma therapy.
